CN1488331A - Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof - Google Patents
Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof Download PDFInfo
- Publication number
- CN1488331A CN1488331A CNA031422314A CN03142231A CN1488331A CN 1488331 A CN1488331 A CN 1488331A CN A031422314 A CNA031422314 A CN A031422314A CN 03142231 A CN03142231 A CN 03142231A CN 1488331 A CN1488331 A CN 1488331A
- Authority
- CN
- China
- Prior art keywords
- superporous hydrogels
- complex
- acrylic acid
- methyl
- cross
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention discloses an ultra-multiaperture hydrogel compound, making method and application in pharmacy. It contains cross-linked polymer and Carbomer. At least one unsaturated alkene monomer and polyene cross-linking agent polymerize to develop it. The making steps: mix at least one unsaturated alkene monomer, one polyene cross-linking agent, Carbomer and one foaming agent; the mixture develops it on the condition of polymerizing and foaming. It can be used in stomach floating preparation and protein polypeptide oral medicine supplying system.
Description
Technical field
The invention belongs to technical field of polymer materials, be specifically related to a kind of Superporous hydrogels complex, its preparation method and the application in pharmaceutics thereof.
Background technology
Hydrogel is the cross-linked hydrophilic high molecular polymer that contains network structure.It is insoluble in water, but can absorb a large amount of moisture.The research of hydrogel starts from nineteen sixties, because it has character such as biocompatibility and biodegradability, can be widely used in medical science, biology and pharmaceutical field, has up to the present invented multiple hydrogel.
With regard to the expansion character of hydrogel, it can be divided into following two kinds: promptly traditional hydrogel and novel hydrogel.The two most important difference is their swelling properties.The swelling properties of hydrogel is mainly relevant with the porosity of the elasticity of network structure, the having or not of hydrophilic functional group in the high molecular polymer segment, crosslinked degree and high molecular polymer.In addition, interionic interaction and solvent mediation effect is also influential to it.The traditional water gel is because the lower elasticity of its inflexible crystal structure and polymer segment makes that its expansion is very slow.The time that the hydrogel of common tablet size (1 centimetre of diameter, thick 0.5 centimetre) reaches swelling equilibrium is generally several hours, even several days.When using, need swelling hydrogel in advance.And novel Superporous hydrogels (superporous gydrogels) has increased the surface area of hydrogel inside greatly owing to contain a large amount of ducts that is cross-linked with each other, and makes that its suction is very fast, is generally several seconds to several hours.But its mechanical strength is relatively poor.
United States Patent (USP) 6271278 discloses a kind of Superporous hydrogels complex, in the presence of a kind of disintegrating agent and a kind of foaming agent, by one or more ethylenic unsaturation monomers and a kind of polyene cross-linking agent polymerization are formed.This invents disclosed Superporous hydrogels owing to contain a large amount of hydroxy-acid groups, and it has the effect of certain bioadhesive and Profilin enzyme.But the Superporous hydrogels complex, because the adding of disintegrating agent makes the effect of its bioadhesive and Profilin enzyme descend.
Summary of the invention
The object of the present invention is to provide that a kind of speed of expansion is fast, mechanical strength is high and bioadhesive and Profilin enzyme are made Superporous hydrogels complex of making good use of and preparation method thereof, and it uses in pharmaceutics, to overcome the deficiencies in the prior art and defective.
CBP (Carbomer) is the copolymer of poly-alkyl sucrose and poly-alkyl tetramethylolmethane and acrylic crosslinking polymer.Because have a large amount of hydroxy-acid groups in the molecule, itself and polyacrylic acid have closely similar physical property and chemical property, simultaneously, faint cross-bond makes it to have similar suction phenomenon to cross-linked sodium polyacrylate again in structure.CBP can be in water swelling rapidly, but do not dissolve.And the formed gel of CBP has certain intensity and elasticity.Hydroxy-acid group in the CBP molecule can form a large amount of hydrogen bonds, on the one hand it is very easily expanded in water, can produce very big adhered area, contacts with mucosa albumen to greatest extent; On the other hand, acrylic polymer can make between polymer and the mucin and produce viscous effect by hydrogen bond and mucinous interaction.And swelling polymer is fast more, and it and mucin are had an effect just fast more, thereby have guaranteed strong viscosity.
The Superporous hydrogels complex that the present invention proposes, be in Superporous hydrogels, to add Ka Bolin and prepare, it had both had the character of the rapid expanding of Superporous hydrogels, again because of the adding of CBP, mechanical strength increases, and have good bioadhesion performance and to the inhibitory action of protease, thereby make this hydrogel composites help the oral administration of protein and peptide class medicine and be used for the stomach floating preparation.
Superporous hydrogels complex of the present invention contains cross linked polymer and CBP, and has super loose structure, and this polymer is formed by at least a ethylenic unsaturation monomer and polyene cross-linking agent polymerization; Wherein the weight ratio of CBP and polymer is 0.05: 100 to 15: 100, and cross-linking agent and monomeric weight ratio are 0.01: 100 to 10: 100.
Said ethylenic unsaturation monomer can in the salt of the salt of (methyl) acrylic acid, (methyl) acrylic acid salt, (methyl) esters of acrylic acid, (methyl) acrylate or acids, (methyl) acrylic acid amide-type, (methyl) acrylic acid N-alkylamide, (methyl) acrylic acid N-alkylamide and acids, N-vinyl pyrrolidone, acrylamide, acrylamide derivative, Methacrylamide, the methacrylamide derivatives one or more.
Usually used ethylenic unsaturation monomer is one or more in acrylamide, N-N-isopropylacrylamide, 2-hydroxyethyl meth acrylate, 2-hydroxypropyl methyl acrylate, N-vinyl pyrrolidone, acrylic acid, 2-acrylamide-2-methyl isophthalic acid-propane sulfonic acid, the 3-sulfopropyl-acrylic acid potassium salt.
Said cross-linking agent is N, N-methylene-bisacrylamide (Bis), two (methyl) acrylic acid glycol ester, piperazine diacrylamine, glutaraldehyde, chloropropylene oxide, the cross-linking agent that contains 1,2 diol structure, the cross-linking agent that contains Functional Polypeptides and proteinaceous cross-linking agent.
Superporous hydrogels complex of the present invention, its average pore size are 50 μ m to 4000 μ m.Preferred average pore size is 100 μ m to 800 μ m.Because the existence of a large amount of holes and they are interconnected with one another, so this hydrogel composites expands very fast and its time that reaches swelling equilibrium is also very short.The swelling ratio of Superporous hydrogels complex of the present invention is 5 to 2000, and swelling ratio is 5-800 preferably.The time that reaches swelling equilibrium is 1 second to 2 hours, and the swelling equilibrium time is 1 second to 30 minutes preferably.
The above-mentioned Superporous hydrogels complex that the present invention proposes, its preparation method is as follows:
(1) at least a ethylenic unsaturation monomer, a kind of polyene cross-linking agent, CBP and a kind of foaming agent are mixed by weight ratio;
(2) said mixture forms the Superporous hydrogels complex under polymerization and blistered condition.
Wherein the ratio of CBP and polymer (being formed by at least a ethylenic unsaturation monomer and polyene cross-linking agent polymerization) is in 0.05: 100 to 15: 100 scope.The consumption of CBP is too big, it all can not be covered in the polymer in polymerization process, has the part CBP that gelling does not take place.Said ethylenic unsaturation monomer be in the salt of the salt of (methyl) acrylic acid, (methyl) acrylic acid salt, (methyl) esters of acrylic acid, (methyl) acrylate or acids, (methyl) acrylic acid amide-type, (methyl) acrylic acid N-alkylamide, (methyl) acrylic acid N-alkylamide and acids, N-vinyl pyrrolidone, acrylamide, acrylamide derivative, Methacrylamide, the methacrylamide derivatives one or more.
Usually used ethylenic unsaturation monomer is one or more in acrylamide, N-N-isopropylacrylamide, 2-hydroxyethyl meth acrylate, 2-hydroxypropyl methyl acrylate, N-vinyl pyrrolidone, acrylic acid, 2-acrylamide-2-methyl isophthalic acid-propane sulfonic acid, the 3-sulfopropyl-acrylic acid potassium salt.
Said cross-linking agent is N, N-methylene-bisacrylamide, two (methyl) acrylic acid glycol ester, piperazine diacrylamine, glutaraldehyde, chloropropylene oxide, the cross-linking agent that contains 1,2 diol structure, the cross-linking agent that contains Functional Polypeptides and proteinaceous cross-linking agent.Its consumption is that cross-linking agent and monomeric ratio are in 0.01: 100 to 10: 100 scope.Preferred cross-linking agents and monomeric ratio were at 1: 100.Crosslinker concentration is too high, causes that swollen Superporous hydrogels complex becomes frangible, causes the reduction of swelling ratio.Otherwise the concentration of cross-linking agent is too low, causes the Superporous hydrogels complex to become more soft frangible.
Said foaming agent be bicarbonate, carbonate one or more or from outer importing bubble.One or more of wherein commonly used is sodium bicarbonate, sodium carbonate and calcium carbonate.Sodium bicarbonate preferably.Its addition is the 0.5-1.5 weight ratio that provides protic monomer.
Two necessary conditions that form the Superporous hydrogels complex are polymerization and foaming.Before polymerization and bubbling, should add needed water earlier.In order to prepare homogeneous phase Superporous hydrogels complex, polymerization and foaming should take place simultaneously.Because bubbling process is short and very difficult stabilise bubbles is longer than a few minutes, for catching the bubble in the polymer network, when bubble stabilizes gelling must take place.
Blistered method is varied, the chemistry or the mechanical means such as expansion of dissolved gas when comprising volatilization, chemical reaction, the release of pressure of thermal decomposition, mechanical shaking, the low-boiling point liquid of chemical reagent.The size in the consumption decision bubble aperture of foaming agent and the porosity of Superporous hydrogels complex.After bubble produces, stable in gelatinization for making it, need to use foam stabiliser, it comes stable foam by reducing film-aerosphere surface tension and increasing film viscosity.。Ideal foam stabiliser should be the beginning of foam stabilization to gelatinization.Pluronic F127 (poloxamer) is a kind of foam stabiliser preferably, and the time of its stable foam is longer.But its consumption has certain requirement, and foam stabilization effect preferably can not be provided very little, and surpasses a certain amount of effect that does not reach stable foam equally.In general, its consumption is 0.4-0.7% (W/W).Used card ripple Zhu among the present invention, along with the increase of the consumption that blocks the ripple Zhu, the generation that can observe bubble highly increases.And if the addition of CBP is suitable, the stability of bubble increases.CBP has assosting effect to bubble stable.
In the said method, before polymerization and bubbling, in mixture, also can add initiator and catalyst, to improve polymerization speed.
Among the present invention, when having acid to exist, select for use sodium bicarbonate to prepare the Superporous hydrogels complex, because sodium bicarbonate-acid system has the advantage that other gas injection technology does not have as foaming agent.Its safe, cheap, easy use, and allow the artificial amount of controlling the gas that forms the foamy time and in polymerization process, import.
Can reach fast gelation by control monomer (kind and concentration), initiator (kind and concentration), temperature and solvent.Common water miscible acrylates, methacrylate and acrylamide gelling are very fast, and therefore, preferred above-mentioned monomer prepares the Superporous hydrogels complex.
Preferably use Ammonium persulfate. as initiator, N, N, N ', N '-tetramethylethylenediamine (TMEDA) is as catalyst, and initiator and catalyst consumption can influence polymeric speed.Usually, the concentration of Ammonium persulfate. and N, N, N ', the concentration of N '-tetramethylethylenediamine is about monomeric 1.5-2.5% (W/W).
The assay method of the swelling ratio of Superporous hydrogels complex of the present invention, density and bioadhesion power is as follows:
The mensuration of swelling ratio: swelling ratio is defined as Q=(Ws-Wd)/Wd, and wherein Ws is the weight of the Superporous hydrogels complex after the swelling, and Wd is the weight of dried Superporous hydrogels complex.The dried Superporous hydrogels complex of at first weighing obtains Wd, and sample is placed excessive distilled water, regularly takes out with the container of band screen cloth, removes remaining water in the screen cloth, weighs then, obtains Ws, can try to achieve swelling ratio Q.
The mensuration of density: density is d=Wd/Vd, and wherein Wd is the weight of dried Superporous hydrogels complex, and Vd is the volume of Superporous hydrogels complex.Wherein Vd utilizes the solvent replacing method to record, and soon the Superporous hydrogels complex places and records diameter and cylindrical test tube height, that normal hexane is housed, learns Vd by the variation of height, thus the density of trying to achieve.
The mensuration of bioadhesion power: get fresh gastric mucosa and the mucous membrane of small intestine (not damaging mucous layer) of rat, Superporous hydrogels is contacted with mucosa with fixed volume, placed 10 minutes, measure with improved precision torsion balance.Required power was bioadhesion power when hydrogel separated with mucosa.
The density of table 1 Superporous hydrogels, swelling ratio, swelling time and bioadhesion power (n=3)
Dried Superporous hydrogels
Swelling time bioadhesion power sample
Swelling ratio
Density (the g/cm of complex
3)
(min) (mg/mm
2)
1 0.84±0.05 138±16 10±3 23.6±10.2
2 0.68±0.02 146±11 8±4 25.3±12.5
3 0.98±0.02 75±8 90±14 32.6±13.1
4 0.80±0.06 149±21 12±5 24.5±11.3
5 0.73±0.09 131±9 9±3 28.3±12.9
6 0.96±0.01 83±11 86±18 35.4±15.6
*: sample 1-6 is made by embodiment 1-6.
Superporous hydrogels complex provided by the invention, its inside is loose structure, outside hole is less, similar traditional hydrogel, thereby its mechanical strength is better.
Superporous hydrogels complex of the present invention has good inhibitory effect to trypsin.
Superporous hydrogels complex of the present invention, less because of its density, it is very fast to expand, and mechanical strength better and to gastric mucosa has adhesive capacity, can be used for the preparation of stomach floating preparation.
Superporous hydrogels complex of the present invention, fast because of its swelling, to the adhesive attraction of mucous membrane of small intestine and to the inhibitory action of protease, it can be used for the oral administration of protein and peptide medicine.
The invention has the advantages that:
(1) CBP has the effect of auxiliary bubble stabilizes, makes the easier row of preparation of Superporous hydrogels complex.
(2) CBP that is added has quick swollen characteristics, and the complex that itself and Superporous hydrogels form still has quick swollen characteristic;
(3) because the appearance of outside similar traditional water gel makes that the mechanical strength of this Superporous hydrogels complex is better;
(4) after the adding appropriate amount of CBP, the density of this Superporous hydrogels complex is less, helps the stomach floating preparation;
(5) adding of CBP makes this Superporous hydrogels complex have bioadhesion effect and protease inhibitory action, helps the oral administration of protein and peptide medicine.
The specific embodiment
Embodiment 1, poly-(acrylic acid and acrylamide)-CBP Superporous hydrogels complex
In tall regular weighing bottle, add following ingredients successively: the acrylamide of 300 μ l 50%; The acrylic acid of 200 μ l 50%; 70 μ l 2.5%Bis; 300 μ l distilled waters; 30 μ l 10%Pluronic F127; The Ammonium persulfate. of 25 μ l 20%; 100 μ l 0.4%Carbopol934P; 25 μ l 15%TEMED.After adding every kind of composition, gelling adding in preceding 2 minutes 100mg sodium bicarbonate, vortex vibration 20 seconds are taking place in vortex mixed solution.Will be under the Superporous hydrogels complex room temperature solidify 10 minutes 55 ℃ of dryings 20 hours.
Embodiment 2, poly-(acrylic acid and acrylamide)-CBP Superporous hydrogels complex
In tall regular weighing bottle, add following ingredients successively: the acrylamide of 300 μ l 50%; The acrylic acid of 200 μ l 50%; 70 μ l 2.5%Bis; 300 μ l distilled waters; 30 μ l 10%Pluronic F127; The Ammonium persulfate. of 25 μ l 20%; 12mg Carbopol934P; 25 μ l 15%TEMED.After adding every kind of composition, gelling adding in preceding 2 minutes 100mg sodium bicarbonate, vortex vibration 20 seconds are taking place in vortex mixed solution.Will be under the Superporous hydrogels complex room temperature solidify 10 minutes 55 ℃ of dryings 20 hours.
Embodiment 3, poly-(acrylic acid and acrylamide)-CBP Superporous hydrogels complex
In tall regular weighing bottle, add following ingredients successively: the acrylamide of 300 μ l 50%; The acrylic acid of 200 μ l 50%; 70 μ l 2.5%Bis; 700 μ l distilled waters; 30 μ l 10%Pluronic F127; The Ammonium persulfate. of 25 μ l 20%; 50mg Carbopol934P; 25 μ l 15%TEMED.After adding every kind of composition, gelling adding in preceding 2 minutes 100mg sodium bicarbonate, vortex vibration 20 seconds are taking place in vortex mixed solution.Will be under the Superporous hydrogels complex room temperature solidify 10 minutes 55 ℃ of dryings 20 hours.
Embodiment 4, poly-(acrylic acid and acrylamide)-CBP Superporous hydrogels complex
In tall regular weighing bottle, add following ingredients successively: the acrylamide of 300 μ l 50%; The acrylic acid of 200 μ l 50%; 70 μ l 2.5%Bis; 300 μ l distilled waters; 30 μ l 10%Pluronic F127; The Ammonium persulfate. of 25 μ l 20%; 100 μ l 0.4%Carbopol974P; 25 μ l 15%TEMED.After adding every kind of composition, gelling adding in preceding 2 minutes 100mg sodium bicarbonate, vortex vibration 20 seconds are taking place in vortex mixed solution.Will be under the Superporous hydrogels complex room temperature solidify 10 minutes 55 ℃ of dryings 20 hours.
Embodiment 5, poly-(acrylic acid and acrylamide)-CBP Superporous hydrogels complex
In tall regular weighing bottle, add following ingredients successively: the acrylamide of 300 μ l 50%; The acrylic acid of 200 μ l 50%; 70 μ l 2.5%Bis; 300 μ l distilled waters; 30 μ l 10%Pluronic F127; The Ammonium persulfate. of 25 μ l 20%; 12mg Carbopol974P; 25 μ l 15%TEMED.After adding every kind of composition, gelling adding in preceding 2 minutes 100mg sodium bicarbonate, vortex vibration 20 seconds are taking place in vortex mixed solution.Will be under the Superporous hydrogels complex room temperature solidify 10 minutes 55 ℃ of dryings 20 hours.
Embodiment 6, poly-(acrylic acid and acrylamide)-CBP Superporous hydrogels complex
In tall regular weighing bottle, add following ingredients successively: the acrylamide of 300 μ l 50%; The acrylic acid of 200 μ l 50%; 70 μ l 2.5%Bis; 700 μ l distilled waters; 30 μ l 10%Pluronic F127; The Ammonium persulfate. of 25 μ l 20%; 50mg Carbopol974P; 25 μ l 15%TEMED.After adding every kind of composition, gelling adding in preceding 2 minutes 100mg sodium bicarbonate, vortex vibration 20 seconds are taking place in vortex mixed solution.Will be under the Superporous hydrogels complex room temperature solidify 10 minutes 55 ℃ of dryings 20 hours.
Embodiment 7, polyacrylamide-CBP Superporous hydrogels complex
In tall regular weighing bottle, add following ingredients successively: the acrylamide of 500 μ l 50%; 100 μ l 2.5%Bis; 300 μ l distilled waters; 40 μ l 10%Pluronic F127; 10 μ l acrylic acid; The Ammonium persulfate. of 20 μ l 20%; 12mgCarbopol934P; 20 μ l 15%TEMED.After adding every kind of composition, gelling adding in preceding 2 minutes 50mg sodium bicarbonate, vortex vibration 20 seconds are taking place in vortex mixed solution.Will be under the Superporous hydrogels complex room temperature solidify 10 minutes 55 ℃ of dryings 20 hours.
Embodiment 8, polyacrylic acid-CBP Superporous hydrogels complex
In tall regular weighing bottle, add following ingredients successively: the acrylic acid of 300 μ l 50% (neutralizing); 100 μ l 2.5%Bis; 300 μ l distilled waters; 40 μ l 10%Pluronic F127; The Ammonium persulfate. of 20 μ l 20%; 12mgCarbopol934P; 20 μ l 15%TEMED.After adding every kind of composition, gelling adding in preceding 2 minutes 100mg sodium bicarbonate, vortex vibration 20 seconds are taking place in vortex mixed solution.Will be under the Superporous hydrogels complex room temperature solidify 10 minutes 55 ℃ of dryings 20 hours.
Embodiment 9,2-hydroxyethyl meth acrylate-CBP Superporous hydrogels complex
In tall regular weighing bottle, add following ingredients successively: 300 μ l 2-hydroxyethyl meth acrylates; 60 μ l 2.5%Bis; 60 μ l 10%Pluronic F127; Vortex mixed; 60 ℃ of insulations add the Ammonium persulfate. of 20 μ l 20%; 12mgCarbopol934P; 20 μ l 15%TEMED.After adding every kind of composition, gelling adding in preceding 2 minutes 50mg sodium bicarbonate, vortex vibration 20 seconds are taking place in vortex mixed solution.Will be under the Superporous hydrogels complex room temperature solidify 10 minutes 55 ℃ of dryings 20 hours.
The Superporous hydrogels complex that the foregoing description makes all has good physics and biological property, specifically is shown in Table 1.
Embodiment 10 aspirin stomach floating preparations
The aspirin aqueous solution of preparation 2mg/ml; Take out 20ml, embodiment 5 gained samples are added wherein; After treating that it absorbs the aspirin aqueous solution fully, under the room temperature dry 2 days; No. 0 capsule pack into promptly.
Embodiment 11 oral insulin drug-supplying systems
Insulin at first with the HCl dissolving of 0.1N, adds the solution that water makes 2mg/ml; Take out 15ml, embodiment 5 gained samples are added wherein; After treating that it absorbs insulin solutions fully, under the room temperature dry 2 days; No. 0 enteric coated capsule pack into promptly.
Claims (15)
1, a kind of Superporous hydrogels complex is characterized in that containing cross linked polymer and CBP, and has super loose structure, and this polymer is formed by at least a ethylenic unsaturation monomer and polyene cross-linking agent polymerization; Wherein, the part by weight of CBP and polymer is 0.05: 100 to 15: 100; Cross-linking agent and monomeric part by weight are 0.01: 100 to 10: 100.
2, Superporous hydrogels complex according to claim 1, it is characterized in that said ethylenic unsaturation monomer in the salt of the salt of (methyl) acrylic acid, (methyl) acrylic acid salt, (methyl) esters of acrylic acid, (methyl) acrylate or acids, (methyl) acrylic acid amide-type, (methyl) acrylic acid N-alkylamide, (methyl) acrylic acid N-alkylamide and acids, N-vinyl pyrrolidone, acrylamide, acrylamide derivative, Methacrylamide, the methacrylamide derivatives one or more.
3, Superporous hydrogels complex according to claim 1 is characterized in that used ethylenic unsaturation monomer is one or more in acrylamide, N-N-isopropylacrylamide, 2-hydroxyethyl meth acrylate, 2-hydroxypropyl methyl acrylate, N-vinyl pyrrolidone, acrylic acid, 2-acrylamide-2-methyl isophthalic acid-propane sulfonic acid, the 3-sulfopropyl-acrylic acid potassium salt.
4, Superporous hydrogels complex according to claim 1, it is characterized in that used cross-linking agent is N, N-methylene-bisacrylamide (Bis), two (methyl) acrylic acid glycol ester, piperazine diacrylamine, glutaraldehyde, chloropropylene oxide, the cross-linking agent that contains 1,2 diol structure, the cross-linking agent that contains Functional Polypeptides and proteinaceous cross-linking agent.
5,, it is characterized in that its average pore size is 50 μ m to 4000 μ m according to the described Superporous hydrogels complex of one of claim 1-4.
6, Superporous hydrogels complex according to claim 5 is characterized in that its average pore size is 100 μ m to 800 μ m.
7, Superporous hydrogels complex according to claim 1 is characterized in that its swelling ratio is 5 to 2000, and the time that reaches swelling equilibrium is 1 second to 2 hours.
8, a kind of preparation method as the described Superporous hydrogels complex of one of claim 1-7 is characterized in that concrete steps are as follows:
(1) at least a ethylenic unsaturation monomer, a kind of polyene cross-linking agent, CBP and a kind of foaming agent are mixed by weight proportion;
(2) said mixture forms the Superporous hydrogels complex under polymerization and blistered condition.
9, the preparation method of Superporous hydrogels complex according to claim 8, it is characterized in that said foaming agent be bicarbonate, carbonate one or more or from outer importing bubble.
10, the preparation method of Superporous hydrogels complex according to claim 9 is characterized in that said foaming agent is a sodium bicarbonate.
11, the preparation method of Superporous hydrogels complex according to claim 8 is characterized in that adding entry in mixture before polymerization and bubbling.
12, the preparation method of Superporous hydrogels complex according to claim 8 is characterized in that adding foam stabiliser in mixture before polymerization and bubbling.
13, the preparation method of Superporous hydrogels complex according to claim 8 is characterized in that adding initiator and catalyst in mixture before polymerization and bubbling.
14, each the application of Superporous hydrogels complex in the stomach floating preparation among the claim 1-7.
15, each the application of Superporous hydrogels complex in the protein and peptide oral administration system among the claim 1-7.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03142231 CN1253147C (en) | 2003-08-13 | 2003-08-13 | Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03142231 CN1253147C (en) | 2003-08-13 | 2003-08-13 | Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1488331A true CN1488331A (en) | 2004-04-14 |
| CN1253147C CN1253147C (en) | 2006-04-26 |
Family
ID=34155669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03142231 Expired - Fee Related CN1253147C (en) | 2003-08-13 | 2003-08-13 | Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1253147C (en) |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101836970A (en) * | 2010-04-13 | 2010-09-22 | 南京大学 | Polyacrylic acid nano-gel microspheres, preparation method and application thereof |
| US8513353B2 (en) | 2009-03-19 | 2013-08-20 | Agency For Science, Technology And Research | Forming copolymer from bicontinuous microemulsion comprising monomers of different hydrophilicity |
| CN103773532A (en) * | 2014-01-27 | 2014-05-07 | 华南理工大学 | Method for purifying acid gas in natural gas |
| CN104288095A (en) * | 2014-01-15 | 2015-01-21 | 南京大学 | Floating gel for delivering pharmacological active substances in bladder and pharmaceutical preparation thereof |
| CN106470673A (en) * | 2014-02-25 | 2017-03-01 | 奥库利维公司 | The polymer formulations stimulating for nose tear |
| CN107591540A (en) * | 2017-08-27 | 2018-01-16 | 长沙小新新能源科技有限公司 | A kind of preparation method of biological fuel cell anode material |
| US10328262B2 (en) | 2010-11-16 | 2019-06-25 | The Board Of Trustees Of The Leland Stanford Junior University | Stimulation devices and methods |
| CN110124245A (en) * | 2019-06-04 | 2019-08-16 | 北京理工大学 | Foam Sodium Alginate Hydrogel Films and preparation method thereof, extinguishing device |
| US10426958B2 (en) | 2015-12-04 | 2019-10-01 | Oculeve, Inc. | Intranasal stimulation for enhanced release of ocular mucins and other tear proteins |
| US10537469B2 (en) | 2013-03-12 | 2020-01-21 | Oculeve, Inc. | Implant delivery devices, systems, and methods |
| US10610695B2 (en) | 2014-10-22 | 2020-04-07 | Oculeve, Inc. | Implantable device for increasing tear production |
| US10610095B2 (en) | 2016-12-02 | 2020-04-07 | Oculeve, Inc. | Apparatus and method for dry eye forecast and treatment recommendation |
| US10722718B2 (en) | 2010-11-16 | 2020-07-28 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for treatment of dry eye |
| US10722713B2 (en) | 2014-07-25 | 2020-07-28 | Oculeve, Inc. | Stimulation patterns for treating dry eye |
| US10780273B2 (en) | 2014-10-22 | 2020-09-22 | Oculeve, Inc. | Stimulation devices and methods for treating dry eye |
| US10799695B2 (en) | 2013-04-19 | 2020-10-13 | Oculeve, Inc. | Nasal stimulation devices and methods |
| US10918864B2 (en) | 2016-05-02 | 2021-02-16 | Oculeve, Inc. | Intranasal stimulation for treatment of meibomian gland disease and blepharitis |
| CN112370418A (en) * | 2020-11-20 | 2021-02-19 | 湖北科技学院 | Radiation synthesis method of superporous hydrogel-based gastric retention agent |
| US10940310B2 (en) | 2016-02-19 | 2021-03-09 | Oculeve, Inc. | Nasal stimulation for rhinitis, nasal congestion, and ocular allergies |
| CN113613631A (en) * | 2019-10-11 | 2021-11-05 | 牛津医疗产品有限公司 | Plasticized superporous hydrogels |
| CN114853954A (en) * | 2022-07-06 | 2022-08-05 | 山东诺尔生物科技有限公司 | Preparation method of carbomer resin and carbomer resin |
-
2003
- 2003-08-13 CN CN 03142231 patent/CN1253147C/en not_active Expired - Fee Related
Cited By (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8513353B2 (en) | 2009-03-19 | 2013-08-20 | Agency For Science, Technology And Research | Forming copolymer from bicontinuous microemulsion comprising monomers of different hydrophilicity |
| CN101836970A (en) * | 2010-04-13 | 2010-09-22 | 南京大学 | Polyacrylic acid nano-gel microspheres, preparation method and application thereof |
| US10835748B2 (en) | 2010-11-16 | 2020-11-17 | Oculeve, Inc. | Stimulation devices and methods |
| US10722718B2 (en) | 2010-11-16 | 2020-07-28 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for treatment of dry eye |
| US11771908B2 (en) | 2010-11-16 | 2023-10-03 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for treatment of dry eye |
| US10328262B2 (en) | 2010-11-16 | 2019-06-25 | The Board Of Trustees Of The Leland Stanford Junior University | Stimulation devices and methods |
| US10537469B2 (en) | 2013-03-12 | 2020-01-21 | Oculeve, Inc. | Implant delivery devices, systems, and methods |
| US10799695B2 (en) | 2013-04-19 | 2020-10-13 | Oculeve, Inc. | Nasal stimulation devices and methods |
| US10835738B2 (en) | 2013-04-19 | 2020-11-17 | Oculeve, Inc. | Nasal stimulation devices and methods |
| US10967173B2 (en) | 2013-04-19 | 2021-04-06 | Oculeve, Inc. | Nasal stimulation devices and methods for treating dry eye |
| CN104288095A (en) * | 2014-01-15 | 2015-01-21 | 南京大学 | Floating gel for delivering pharmacological active substances in bladder and pharmaceutical preparation thereof |
| CN104288095B (en) * | 2014-01-15 | 2017-07-07 | 南京大学 | A kind of floating gel and its pharmaceutical preparation for delivering pharmacological active substance in bladder |
| CN103773532B (en) * | 2014-01-27 | 2015-12-09 | 华南理工大学 | The purifying treatment method of sour gas in a kind of Sweet natural gas |
| CN103773532A (en) * | 2014-01-27 | 2014-05-07 | 华南理工大学 | Method for purifying acid gas in natural gas |
| CN106470673A (en) * | 2014-02-25 | 2017-03-01 | 奥库利维公司 | The polymer formulations stimulating for nose tear |
| US10799696B2 (en) | 2014-02-25 | 2020-10-13 | Oculeve, Inc. | Polymer formulations for nasolacrimal stimulation |
| CN106470673B (en) * | 2014-02-25 | 2020-01-31 | 奥库利维公司 | Polymer formulations for nasolacrimal stimulation |
| US10722713B2 (en) | 2014-07-25 | 2020-07-28 | Oculeve, Inc. | Stimulation patterns for treating dry eye |
| US10610695B2 (en) | 2014-10-22 | 2020-04-07 | Oculeve, Inc. | Implantable device for increasing tear production |
| US10780273B2 (en) | 2014-10-22 | 2020-09-22 | Oculeve, Inc. | Stimulation devices and methods for treating dry eye |
| US10426958B2 (en) | 2015-12-04 | 2019-10-01 | Oculeve, Inc. | Intranasal stimulation for enhanced release of ocular mucins and other tear proteins |
| US10940310B2 (en) | 2016-02-19 | 2021-03-09 | Oculeve, Inc. | Nasal stimulation for rhinitis, nasal congestion, and ocular allergies |
| US10918864B2 (en) | 2016-05-02 | 2021-02-16 | Oculeve, Inc. | Intranasal stimulation for treatment of meibomian gland disease and blepharitis |
| US10610095B2 (en) | 2016-12-02 | 2020-04-07 | Oculeve, Inc. | Apparatus and method for dry eye forecast and treatment recommendation |
| CN107591540A (en) * | 2017-08-27 | 2018-01-16 | 长沙小新新能源科技有限公司 | A kind of preparation method of biological fuel cell anode material |
| CN110124245A (en) * | 2019-06-04 | 2019-08-16 | 北京理工大学 | Foam Sodium Alginate Hydrogel Films and preparation method thereof, extinguishing device |
| CN113613631A (en) * | 2019-10-11 | 2021-11-05 | 牛津医疗产品有限公司 | Plasticized superporous hydrogels |
| CN112370418A (en) * | 2020-11-20 | 2021-02-19 | 湖北科技学院 | Radiation synthesis method of superporous hydrogel-based gastric retention agent |
| CN114853954A (en) * | 2022-07-06 | 2022-08-05 | 山东诺尔生物科技有限公司 | Preparation method of carbomer resin and carbomer resin |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1253147C (en) | 2006-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1253147C (en) | Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof | |
| CN1302050C (en) | Interpenetrating network polymer type super porous aquogel, its prepn. method and application | |
| US5603955A (en) | Enhanced loading of solutes into polymer gels | |
| US5750585A (en) | Super absorbent hydrogel foams | |
| Zhang et al. | Synthesis, characterization and controlled drug release of thermosensitive IPN–PNIPAAm hydrogels | |
| US7988992B2 (en) | Superporous hydrogels for heavy-duty applications | |
| ES2313879T3 (en) | USEFUL HYDROGEL COMPOSITIONS FOR THE PROLONGED RELEASE OF MACROMOLECULES, AND MANUFACTURING PROCEDURES OF THE SAME. | |
| Zhang et al. | Fabrication and characterization of microgel-impregnated, thermosensitive PNIPAAm hydrogels | |
| JP2001181924A (en) | Polymer having biologically active agent | |
| CN1835792A (en) | Injectable hydrogel microspheres from aqueous two-phase system | |
| CN1816385A (en) | Hydrophilic membrane and process for making the same | |
| KR20110069093A (en) | Vinyl alcohol co-polymer cryogels, vinyl alcohol co-polymers, and methods and products thereof | |
| CN1908035A (en) | Nanometer composite hydrogel and preparation method thereof | |
| US20020122828A1 (en) | Hybrid porous materials for controlled release | |
| CN106619488A (en) | Preparation method and application of microsphere-loaded PHEMA hydrogel drug carrying body | |
| CN101885906A (en) | Degradable biological hydrogel and preparation method thereof | |
| CN1219874A (en) | Preparation for percutaneous administration | |
| Bajpai et al. | In vitro release dynamics of insulin from a loaded hydrophilic polymeric network | |
| Gharat et al. | Compressive review on hydrogel | |
| Shahruzzaman et al. | Semi-IPN Systems for Drug Delivery | |
| KR20220096694A (en) | Superabsorbent microporous hydrogel sponge and preparation method thereof | |
| US20080206339A1 (en) | Very-pure superporous hydrogels having outstanding swelling properties | |
| Peppas et al. | Glucose-responsive hydrogels | |
| CN1291759C (en) | Coblended contact glue of poly N-ethenyl pyrrolidone and polyvinyl alcohol and its use | |
| CN1742706A (en) | Water-soluble medicine degradable polymer microcapsule injecta and preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |